InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: None

Monday, 11/04/2019 12:38:09 PM

Monday, November 04, 2019 12:38:09 PM

Post# of 3881
We've never seen anything close to this volume before, so despite the modest post-open gains, it bodes very well for the near term IMO. Today's FDA approval significantly de-risks this stock. I cannot see how, given the phenominal clinical results, this drug doesn't start to see commercial traction and start to generate material revenues for RedHill in 2020. And they have a few more blockbuster candidates in their quiver.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News